T. Cloughesy, W. Cavenee, and P. Mischel, Glioblastoma: From Molecular Pathology to Targeted Treatment, Annual Review of Pathology: Mechanisms of Disease, vol.9, issue.1, pp.1-25, 2014.
DOI : 10.1146/annurev-pathol-011110-130324

S. Weathers and M. Gilbert, Advances in treating glioblastoma. F1000prime reports, p.46, 2014.

J. Huse, E. Holland, and L. Deangelis, Glioblastoma: molecular analysis and clinical implications. Annual review of medicine, pp.59-70, 2013.

J. Bradley, G. Ramirez, and J. Hagood, Roles and regulation of Thy-1, a context-dependent modulator of cell phenotype, BioFactors, vol.79, issue.Part 5, pp.258-65, 2009.
DOI : 10.1128/MCB.8.9.3847

C. Wikstrand, F. Grahmann, R. Mccomb, and D. Bigner, Antigenic Heterogeneity of Human Anaplastic Gliomas and Glioma-derived Cell Lines Defined by Monoclonal Antibodies, Journal of Neuropathology and Experimental Neurology, vol.44, issue.3, pp.229-270, 1985.
DOI : 10.1097/00005072-198505000-00002

J. Kemshead, M. Ritter, S. Cotmore, and M. Greaves, Human Thy-1: Expression on the cell surface of neuronal and and glial cells, Brain Research, vol.236, issue.2, pp.451-61, 1982.
DOI : 10.1016/0006-8993(82)90727-2

E. Hurwitz, R. Arnon, E. Sahar, and Y. Danon, A CONJUGATE OF ADRIAMYCIN AND MONOCLONAL ANTIBODIES TO THY-1 ANTIGEN INHIBITS HUMAN NEUROBLASTOMA CELLS IN VITRO, Annals of the New York Academy of Sciences, vol.207, issue.1 Oncodevelopme, pp.125-161, 1983.
DOI : 10.1073/pnas.77.9.5483

R. Seeger, Y. Danon, S. Rayner, and F. Hoover, Definition of a Thy-1 determinant on human neuroblastoma, glioma, sarcoma, and teratoma cells with a monoclonal antibody, Journal of immunology, vol.128, issue.2, pp.983-992, 1982.

C. Wikstrand, S. Bigner, and D. Bigner, Demonstration of complex antigenic heterogeneity in a human glioma cell line and eight derived clones by specific monoclonal antibodies. Cancer research, pp.3327-3361, 1983.

J. He, Y. Liu, T. Zhu, J. Zhu, F. Dimeco et al., CD90 is identified as a candidate marker for cancer stem cells in primary high-grade gliomas using tissue microarrays. Molecular & cellular proteomics : MCP Tumorigenesis of chemotherapeutic drug-resistant cancer stem-like cells in brain glioma Stem cells and development Functional and molecular characterization of glioblastoma multiforme-derived cancer stem cells, J BUON, vol.111615, issue.133, pp.837-47583, 2007.

G. Liu, X. Yuan, Z. Zeng, P. Tunici, H. Ng et al., Analysis of gene expression and chemoresistance of CD133+ cancer stem cells in glioblastoma Casein kinase 2alpha regulates glioblastoma brain tumor-initiating cell growth through the beta-catenin pathway, Molecular cancer. Oncogene, vol.534, issue.28, pp.3688-99, 2006.

K. Ochs, F. Sahm, C. Opitz, T. Lanz, I. Oezen et al., Immature mesenchymal stem cell-like pericytes as mediators of immunosuppression in human malignant glioma, Journal of Neuroimmunology, vol.265, issue.1-2, pp.493-5041, 2012.
DOI : 10.1016/j.jneuroim.2013.09.011

S. Haeryfar and D. Hoskin, Thy-1: More than a Mouse Pan-T Cell Marker, The Journal of Immunology, vol.173, issue.6, pp.3581-3589, 2004.
DOI : 10.4049/jimmunol.173.6.3581

T. Rege and J. Hagood, Thy-1 as a regulator of cell-cell and cell-matrix interactions in axon regeneration, apoptosis, adhesion, migration, cancer, and fibrosis, The FASEB Journal, vol.20, issue.8, pp.1045-54, 2006.
DOI : 10.1128/MCB.13.10.6385

T. Barker and J. Hagood, Getting a grip on Thy-1 signaling, Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, vol.1793, issue.5, pp.921-924, 2009.
DOI : 10.1016/j.bbamcr.2008.10.004

L. Leyton and J. Hagood, Thy-1 modulates neurological cell-cell and cell-matrix interactions through multiple molecular interactions Advances in neurobiology, pp.3-20, 2014.

T. Avril, S. Saikali, E. Vauleon, A. Jary, A. Hamlat et al., Distinct effects of human glioblastoma immunoregulatory molecules programmed cell death ligand-1 (PDL-1) and indoleamine 2,3-dioxygenase (IDO) on tumour-specific T cell functions, Journal of Neuroimmunology, vol.225, issue.1-2, pp.22-33, 2010.
DOI : 10.1016/j.jneuroim.2010.04.003
URL : https://hal.archives-ouvertes.fr/inserm-00486777

T. Avril, E. Vauleon, A. Hamlat, S. Saikali, A. Etcheverry et al., Human glioblastoma stem-like cells are more sensitive to allogeneic NK and T cell-mediated killing compared with serum-cultured glioblastoma cells. Brain pathology IRE1 signaling is essential for ischemia-induced vascular endothelial growth factor-A expression and contributes to angiogenesis and tumor growth in vivo. Cancer research NIH Image to ImageJ: 25 years of image analysis, Nature methods, vol.22679, issue.257, pp.159-746700, 2007.
URL : https://hal.archives-ouvertes.fr/inserm-00618443

A. Schulte, H. Gunther, H. Phillips, D. Kemming, T. Martens et al., A distinct subset of glioma cell lines with stem cell-like properties reflects the transcriptional phenotype of glioblastomas and overexpresses CXCR4 as therapeutic target Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis, Glia. Cancer cell, vol.599, issue.283, pp.590-602157, 2006.

W. Freije, F. Castro-vargas, Z. Fang, S. Horvath, T. Cloughesy et al., Gene expression profiling of gliomas strongly predicts survival. Cancer research, Donson AM, vol.64, issue.30, pp.6503-6513, 2004.

M. Hemenway, Increased immune gene expression and immune cell infiltration in highgrade astrocytoma distinguish long-term from short-term survivors, Journal of immunology, vol.189, issue.4, pp.1920-1927, 2012.

M. Mazurowski, A. Desjardins, and J. Malof, Imaging descriptors improve the predictive power of survival models for glioblastoma patients, Neuro-Oncology, vol.24, issue.19, pp.1389-94, 2013.
DOI : 10.1093/bioinformatics/btn374

P. Zinn, B. Mahajan, P. Sathyan, S. Singh, S. Majumder et al., Radiogenomic mapping of edema/cellular invasion MRI-phenotypes in glioblastoma multiforme Imaging genomic mapping of an invasive MRI phenotype predicts patient outcome and metabolic dysfunction: a TCGA glioma phenotype research group project. BMC medical genomics Structural and functional changes during epileptogenesis in the mouse model of medial temporal lobe epilepsy, Conference proceedings : Annual International Conference of the IEEE Engineering in Medicine and Biology Society IEEE Engineering in Medicine and Biology Society Annual Conference, pp.25451-34304005, 2011.

J. Hennig, A. Nauerth, and H. Friedburg, RARE imaging: a fast imaging method for clinical MR. Magnetic resonance in medicine, pp.823-856, 1986.

S. Saikali, T. Avril, B. Collet, A. Hamlat, J. Bansard et al., Expression of nine tumour antigens in a series of human glioblastoma multiforme: interest of EGFRvIII, IL- 13Ralpha2, gp100 and TRP-2 for immunotherapy Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer cell, pp.139-4898, 2007.

T. Rege, M. Pallero, C. Gomez, H. Grenett, J. Murphy-ullrich et al., Thy-1, via its GPI anchor, modulates Src family kinase and focal adhesion kinase phosphorylation and subcellular localization, and fibroblast migration, in response to thrombospondin-1/hep I, Experimental Cell Research, vol.312, issue.19, pp.3123752-67, 2006.
DOI : 10.1016/j.yexcr.2006.07.029

A. Bild, G. Yao, J. Chang, Q. Wang, A. Potti et al., Thrombospondin-1-induced focal adhesion disassembly in fibroblasts requires Thy-1 surface expression, lipid raft integrity, and Src activation Oncogenic pathway signatures in human cancers as a guide to targeted therapies Transcriptional profiles of CD133+ and CD133-glioblastoma-derived cancer stem cell lines suggest different cells of origin. Cancer research, The Journal of biological chemistry. Nature, vol.27943970, issue.2270745, pp.23510-23516, 2004.

J. He, Y. Liu, X. Xie, T. Zhu, M. Soules et al., Identification of Cell Surface Glycoprotein Markers for Glioblastoma-Derived Stem-Like Cells Using a Lectin Microarray and LC???MS/MS Approach, WHO classification of tumours of the central nervous system, pp.2565-7297, 2007.
DOI : 10.1021/pr100012p

J. Zhong, A. Paul, S. Kellie, O. Neill, and G. , Mesenchymal Migration as a Therapeutic Target in Glioblastoma, Vehlow A, Cordes N. Invasion as target for therapy of glioblastoma multiforme, pp.430142-430188, 2010.
DOI : 10.1186/1471-2202-9-S2-S4

X. Han, W. Zhang, X. Yang, C. Wheeler, C. Langford et al., The role of Src family kinases in growth and migration of glioma stem cells, International Journal of Oncology, vol.45, issue.1, pp.302-312, 2014.
DOI : 10.3892/ijo.2014.2432

K. Lu, S. Zhu, A. Cvrljevic, T. Huang, S. Sarkaria et al., Fyn and SRC are effectors of oncogenic epidermal growth factor receptor signaling in glioblastoma patients. Cancer research Phosphorylation of dedicator of cytokinesis 1 (Dock180) at tyrosine residue Y722 by Src family kinases mediates EGFRvIII-driven glioblastoma tumorigenesis Suppression of cell invasion on human malignant glioma cell lines by a novel matrix-metalloproteinase inhibitor SI-27: in vitro study, Proceedings of the National Academy of Sciences of the United States of America. Journal of neuro-oncology, vol.6910948, issue.503, pp.6889-983018, 2000.

J. Tonn, S. Kerkau, A. Hanke, H. Bouterfa, J. Mueller et al., Effect of synthetic matrix-metalloproteinase inhibitors on invasive capacity and proliferation of human malignant gliomas in vitro Marked inhibition of tumor growth in a malignant glioma tumor model by a novel synthetic matrix metalloproteinase inhibitor AG3340 Effect of the angiogenesis inhibitor Cilengitide (EMD 121974) on glioblastoma growth in nude mice, al. Cilengitide modulates attachment and viability of human glioma cells, but not sensitivity to irradiation or temozolomide in vitro, pp.764-72845, 1999.

T. Mikkelsen, C. Brodie, S. Finniss, M. Berens, J. Rennert et al., Radiation sensitization of glioblastoma by cilengitide has unanticipated schedule-dependency The motility of glioblastoma tumour cells is modulated by intracellular cofilin expression in a concentration-dependent manner. Cell motility and the cytoskeleton, International journal of cancer Journal international du cancer, vol.12460, issue.113, pp.2719-27153, 2005.

Q. Shi, A. Hjelmeland, S. Keir, L. Song, S. Wickman et al., A novel low-molecular weight inhibitor of focal adhesion kinase, TAE226, inhibits glioma growth, Molecular Carcinogenesis, vol.51, issue.6, pp.488-96, 2007.
DOI : 10.1128/MCB.15.2.954

A. Schultze, S. Decker, J. Otten, A. Horst, G. Vohwinkel et al., TAE226- mediated inhibition of focal adhesion kinase interferes with tumor angiogenesis and vasculogenesis Pharmacologic blockade of FAK autophosphorylation decreases human glioblastoma tumor growth and synergizes with temozolomide SRC regulates actin dynamics and invasion of malignant glial cells in three dimensions Molecular cancer research : MCR, Investigational new drugs. Molecular cancer therapeutics. Angers-Loustau A, vol.28122, issue.6011, pp.825-33162, 2004.

V. Milano, Y. Piao, T. Lafortune, and J. De-groot, Dasatinib-induced autophagy is enhanced in combination with temozolomide in glioma, Molecular Cancer Therapeutics, vol.8, issue.2, pp.394-406, 2009.
DOI : 10.1158/1535-7163.MCT-08-0669

M. Groves, V. Puduvalli, K. Hess, K. Jaeckle, P. Peterson et al., Phase II trial of temozolomide plus the matrix metalloproteinase inhibitor, marimastat, in recurrent and progressive glioblastoma multiforme, PloS one. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, vol.820, issue.64, pp.56505-631383, 2002.

R. Stupp, M. Hegi, T. Gorlia, S. Erridge, J. Perry et al., Cilengitide combined with standard treatment for patients with newly diagnosed glioblastoma with methylated MGMT promoter (CENTRIC EORTC 26071-22072 study): a multicentre, randomised, open-label, phase 3 trial, The Lancet Oncology, vol.15, issue.10, pp.295-3021100, 2006.
DOI : 10.1016/S1470-2045(14)70379-1

L. Lewis-tuffin, R. Feathers, P. Hari, N. Durand, Z. Li et al., trial of dasatinib in target-selected patients with recurrent glioblastoma (RTOG 0627) Src family kinases differentially influence glioma growth and motility, Neurooncology . Molecular oncology, vol.179, issue.679, pp.992-81783, 2015.